Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
about
The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studiesCREG1 heterozygous mice are susceptible to high fat diet-induced obesity and insulin resistance.In vitro inhibition of lipid accumulation induced by oleic acid and in vivo pharmacokinetics of chitosan microspheres (CTMS) and chitosan-capsaicin microspheres (CCMS)A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Diabetes drugs and the incidence of solid cancers: a survey of the current evidence.SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors.Prevalence and impact of obesity in people with haemophilia: Review of literature and expert discussion around implementing weight management guidelines.A systematic review of the interrelation between diet- and surgery-induced weight loss and vitamin D status.Primary cutaneous B-cell lymphoma and chronic leg ulcers in a patient with type 2 diabetes.Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey.Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma in vitro and in vivo.Mu opioid receptor: from pain to glucose metabolism.The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis.Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients.Hyperglycaemia is associated with cancer-related but not non-cancer-related deaths: evidence from the IPC cohort.Adipose tissue deficiency of hormone-sensitive lipase causes fatty liver in mice.Impact of metformin on serum prostate-specific antigen levels: Data from the national health and nutrition examination survey 2007 to 2008.Effects and Mechanisms of Metformin on the Proliferation of Esophageal Cancer Cells In Vitro and In Vivo.Diet and exercise interventions for pediatric cancer patients during therapy: tipping the scales for better outcomes.Translating Mechanism-Based Strategies to Break the Obesity-Cancer Link: A Narrative Review.The effects of metformin on gut microbiota and the immune system as research frontiers.Association of Fast-Food and Full-Service Restaurant Densities With Mortality From Cardiovascular Disease and Stroke, and the Prevalence of Diabetes Mellitus.Disease networks identify specific conditions and pleiotropy influencing multimorbidity in the general populationMetformin and blood cancersSuppression of insulin feedback enhances the efficacy of PI3K inhibitors
P2860
Q33579966-55C10AEE-6F24-4222-AB13-0574BA5FCF64Q33620848-87551881-A2CB-45A4-9E2F-00E96098CCB5Q33810854-A5A7942B-5EFD-440F-B5A4-413B3EA6DCD1Q37728970-372E7A12-00EA-469C-BBE6-1CEFC6B35D02Q38641190-4AE49182-AB13-479F-987F-E4BED84BF12DQ38651175-DAE31315-45A4-468F-9F35-96FE498915F8Q38654762-592F92BF-BAA4-4951-BE30-704FDE1E096DQ38674812-F2CD6E2F-F4BB-4B6C-BD51-7A43D24160BAQ38715839-F429AF8F-FFBC-409E-9565-27C3FDD2A4D6Q38734448-9DE69A4F-AD2B-46DD-976C-18E584D582F1Q40189950-ED04097F-DA3C-47CB-B37D-087BA22CFFD8Q40376269-C3B158A7-E9D9-4C44-AAB2-F5590954DB06Q41050215-DCC8956C-9036-4992-B9E1-0E9CE2F5F20FQ42040539-224F2A93-117D-48C7-B50B-99910C34D1D5Q42316276-A5BEE438-A49A-4EA3-94DB-E945844ED807Q47137580-C3706716-B092-4625-9B52-AB51ED93F9B2Q47169220-1C1D6618-3911-43FB-BD04-BE7429591326Q47203381-95651C9B-6BDD-4A6F-96F4-8EA3BD7EBC51Q48132740-AA123842-CC88-47F6-ACB0-132D066A4F90Q49185314-F4CC9C53-AB18-4061-9FF6-C980CD589105Q49623717-852F5997-AE52-40D0-89E3-24933642887EQ50080770-D9EFB5FB-5F5D-49A2-A7A5-ED0437E0A8A5Q50162842-C20F9575-5A65-4AD3-B82F-BA529D0B32F2Q52552476-F756037E-11FD-4534-BE57-6DBBBDAD2BC4Q55499320-B2AB2BB8-7A61-411B-9735-D5791FE5F1B4Q58107316-A0440E9F-1701-46D5-B534-374A95831741Q58699189-F6ECDC30-D919-486D-A7DC-81DAB07E808AQ59066873-E3BF6CAE-8DC6-421B-900E-88E870C811BC
P2860
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
@ast
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
@en
type
label
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
@ast
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
@en
prefLabel
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
@ast
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
@en
P2093
P1476
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
@en
P2093
Adi J Klil-Drori
Laurent Azoulay
Michael N Pollak
P2888
P356
10.1038/NRCLINONC.2016.120
P407
P577
2016-08-09T00:00:00Z
P6179
1022164376